Kate Sandstrom
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 5
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 2
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 1
- Biosimilars and Bioanalytical Methods 1
- Co-authors
- Ronald M. Bukowski (10 shared papers)Thomas Olencki (7 shared papers)Hema Parmar (1 shared paper)Lawrence H. Schwartz (1 shared paper)Ashok Rakhit (1 shared paper)R Nadeau (1 shared paper)Robert J. Motzer (1 shared paper)Denise McLain (7 shared papers)
- Journals
- Journal of Immunotherapy (2 papers)Journal of Clinical Oncology (1 paper)Investigational New Drugs (1 paper)The Journal of Urology (1 paper)Cancer (1 paper)
- Partner nations
- United StatesSwitzerlandCroatia
In The Last Decade
Kate Sandstrom
13 papers receiving 428 citations
Peers
Comparison fields: 5 of 57
- Immunology 218
- Oncology 181
- Pulmonary and Respiratory Medicine 88
- Biotechnology 25
- Cancer Research 26
Countries citing papers authored by Kate Sandstrom
This map shows the geographic impact of Kate Sandstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Sandstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Sandstrom more than expected).
Fields of papers citing papers by Kate Sandstrom
This network shows the impact of papers produced by Kate Sandstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Sandstrom. The network helps show where Kate Sandstrom may publish in the future.
Co-authors
The 25 scholars most cited alongside Kate Sandstrom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. | 1998 | 196 |
| 2 | Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy. | 1998 | 48 |
| 3 | 2000 | 39 | |
| 4 | 1999 | 33 | |
| 5 | 2020 | 31 | |
| 6 | 1997 | 28 | |
| 7 | Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma. | 1996 | 23 |
| 8 | 1996 | 19 | |
| 9 | Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings. | 1996 | 9 |
| 10 | 1993 | 5 | |
| 11 | 2001 | 4 | |
| 12 | 2020 | 1 | |
| 13 | 1999 | 1 |
About Kate Sandstrom
Kate Sandstrom is a scholar working on Oncology, Immunology, Biotechnology, Surgery and Radiological and Ultrasound Technology, having authored 13 papers that have together received 437 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), Cancer Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Renal cell carcinoma treatment (1 paper), T-cell and B-cell Immunology (1 paper), Biosimilars and Bioanalytical Methods (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Immunology (218 citations), Oncology (181 citations), Pulmonary and Respiratory Medicine (88 citations), Biotechnology (25 citations) and Cancer Research (26 citations). Kate Sandstrom has collaborated with scholars based in United States, Switzerland and Croatia. Frequent co-authors include Ronald M. Bukowski, Thomas Olencki, Hema Parmar, Lawrence H. Schwartz, Ashok Rakhit, R Nadeau, Robert J. Motzer, Denise McLain, James H. Finke and Paul Elson. Their work appears in journals such as Journal of Immunotherapy, Journal of Clinical Oncology, Investigational New Drugs, The Journal of Urology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.